Revolution Medicines (RVMD) Earnings Date, Estimates & Call Transcripts

$39.41
+0.42 (+1.08%)
(As of 05/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(May. 8)
-$0.70 Beat By $0.05
Consensus EPS
(May. 8)
-$0.75
Skip Charts & View Estimated and Actual Earnings Data

RVMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RVMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Revolution Medicines Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.77)($0.70)($0.73)
Q2 20243($0.77)($0.73)($0.75)
Q3 20243($0.79)($0.77)($0.78)
Q4 20243($0.82)($0.80)($0.81)
FY 202412($3.15)($3.00)($3.07)
Q1 20252($0.85)($0.83)($0.84)
Q2 20252($0.88)($0.85)($0.87)
Q3 20252($0.91)($0.88)($0.90)
Q4 20252($0.90)($0.90)($0.90)
FY 20258($3.54)($3.46)($3.50)

RVMD Earnings Date and Information

Revolution Medicines last posted its earnings results on May 8th, 2024. The reported ($0.70) earnings per share for the quarter, beating analysts' consensus estimates of ($0.75) by $0.05. Its revenue was down 100.0% on a year-over-year basis. Revolution Medicines has generated ($3.75) earnings per share over the last year (($3.75) diluted earnings per share). Earnings for Revolution Medicines are expected to decrease in the coming year, from ($3.12) to ($3.54) per share. Revolution Medicines has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Revolution Medicines Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
Estimated)
------- 
5/8/2024Q1 2024($0.75)($0.70)+$0.05($0.70)$1.37 million-    
2/26/2024Q4 2023($0.85)($1.14)($0.29)($1.14)$1.20 million$0.74 million    
11/6/2023Q3 2023($1.01)($0.99)+$0.02($0.99)$0.75 million-    
8/8/2023Q2 2023($0.82)($0.92)($0.10)($0.92)$1.56 million$3.82 million  
5/8/2023Q1 2023($0.84)($0.72)+$0.12($0.72)$2.94 million$7.01 million    
2/27/2023Q4 2022($0.84)($0.63)+$0.21($0.63)$6.75 million$15.33 million
11/7/2022Q3 2022($0.87)($0.87)-($0.87)$8.57 million$3.36 million    
8/9/2022Q2 2022($0.87)($0.82)+$0.05($0.82)$8.75 million$9.12 million
5/9/2022Q1 2022($0.82)($0.78)+$0.04($0.78)$10.00 million$7.58 million    
2/28/2022Q4 2021($0.65)($0.71)($0.06)($0.71)$8.20 million$9.46 million    
11/10/2021Q3 2021($0.62)($0.72)($0.10)($0.72)$9.65 million$1.10 million    
8/11/2021Q2 2021($0.56)($0.60)($0.04)($0.60)$10.81 million$8.70 million    

Revolution Medicines Earnings - Frequently Asked Questions

When is Revolution Medicines's earnings date?

Revolution Medicines has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on RVMD's earnings history.

Did Revolution Medicines beat their earnings estimates last quarter?

In the previous quarter, Revolution Medicines (NASDAQ:RVMD) reported ($0.70) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.75) by $0.05. Learn more on analysts' earnings estimate vs. RVMD's actual earnings.

How can I listen to Revolution Medicines's earnings conference call?

The conference call for Revolution Medicines's latest earnings report can be listened to online. Listen to Conference Call

How can I read Revolution Medicines's conference call transcript?

The conference call transcript for Revolution Medicines's latest earnings report can be read online. Read Transcript

How much revenue does Revolution Medicines generate each year?

Revolution Medicines (NASDAQ:RVMD) has a recorded annual revenue of $11.58 million.

How much profit does Revolution Medicines generate each year?

Revolution Medicines (NASDAQ:RVMD) has a recorded net income of -$436.37 million. RVMD has generated -$3.75 earnings per share over the last four quarters.

What is Revolution Medicines's EPS forecast for next year?

Revolution Medicines's earnings are expected to decrease from ($3.12) per share to ($3.54) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:RVMD) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners